<DOC>
	<DOCNO>NCT00515177</DOCNO>
	<brief_summary>Chronic insomnia major public health problem affect 10 % adult associate serious distressful health consequence depression , anxiety reduce quality life . Sleep medication effective , side effect , cost uncertain long term efficacy call non-pharmacologic alternative . Mindfulness-Based Stress Reduction ( MBSR ) , standardized program training mindfulness meditation yoga , promise new approach treat chronic insomnia . MBSR develop facilitate adaptation stressor medical illness . It hypothesize mindfulness training reduces arousal unhelpful cognition promote sustain chronic insomnia . The Mindfulness Versus Pharmacotherapy trial ( MVP # 1 ) pilot study design establish feasibility determine optimal design full-scale trial compare MBSR prescribed sleep medication treatment chronic insomnia . For pilot , randomize person primary chronic insomnia ( actual sample 30 person ) 2 group : 1 ) MBSR ( 8-weeks group instruction follow 3-months home practice ) ; 2 ) PCT ( 3 mg LUNESTA ( eszopiclone ) nightly 8-weeks follow 3-months `` need '' use ) . Both group telephone monitor side effect , adherence tracking , objective sleep assessment actigraphy . The primary outcome sleep quality , sleep quantity insomnia severity assess well-validated self-report scale , objective sleep parameter measure wrist actigraphy , depression anxiety symptom , health-related quality life workplace productivity . We hypothesize MBSR group improve sleep outcome . Outcomes assess 8-weeks ( end active intervention phase ) 5 month follow-up . Outcomes compare baseline value measure reflect propose mechanism action determine clinically important impact likely obtainable full-scale trial . After follow-up data collect , participant invite participate focus group share impression study intervention identify issue could address full-scale trial . Our long-range goal provide evidence-based recommendation safe , practical cost-effective non-pharmacologic treatment option chronic insomnia .</brief_summary>
	<brief_title>Mindfulness Versus Pharmacotherapy Chronic Insomnia : A Pilot Study</brief_title>
	<detailed_description>The NIH 's 2003 National Sleep Disorders Research Plan define insomnia `` difficulty fall asleep , difficulty stay asleep short sleep duration , despite adequate opportunity sleep , '' estimate affect 30 % 40 % adult . The prevalence chronic insomnia , define sleep disturbance 4 week , sleep disruption daytime impairment , regular , nightly sleep difficulty , 10 % general population , high rate among woman , old adult clinical population . Total direct indirect cost insomnia estimate roughly $ 113 billion annually . While 3 million 70 million Americans insomnia take prescription medication , annual prescription drug cost insomnia exceed $ 2.1 billion dollar . Mindfulness-Based Stress Reduction ( MBSR ) , standardized group program training mindfulness meditation yoga , promise intervention lifelong self-management chronic insomnia . Mindfulness meditation training find improve sleep outcome patient chronic illness . Meditation may define self-regulation attention , mindfulness describe pay attention particular , intentional way , moment-by-moment , without judge . MBSR originate Stress Reduction Clinic University Massachusetts Medical Center currently use 250 clinic , hospital , health maintenance organization US abroad ( www.umassmed.edu/cfm/srp/ ) . MVP # 1 pilot study establish feasibility , refine procedure determine optimal design plan full-scale trial . An active control drug , eszopiclone widely use FDA approve prescription sleep medication , include pilot provide benchmark efficacy . Outcomes evaluated determine clinically important impact likely obtainable future full-scale trial .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>Chronic insomnia define ) sleep onset latency and/or wake sleep onset longer 30 minute per night , least 3 night per week ; b ) Insomnia duration least 6 month , selfreport ; c ) minimum 1 daytime complaint selfreport ( e.g . fatigue , mood disturbance ) ; Between 18 65 year age ; Englishspeaking ; Literate ; Mentally intact ; Interested either medication mindbody intervention ; Able attend weekly class Minnesota Metro area ; Able comply study sleep monitoring requirement ; Willing complete inform consent process . Sleep apnea primary sleep disorder suspect responsible insomnia ; Mental disorder substance ( include medication ) suspect responsible insomnia ; General medical condition suspect responsible insomnia ; Medically unstable ( hospital admission nonelective purpose last 3 month major surgery plan next 3 month ) ; Serious preexist mental health issue : suicidality think disorder/psychosis ; delirium substance abuse ; Treatment depression anxiety initiation therapy dosage change within last 6 month ; Use nonprescription sleep aid unwilling unable discontinue study ; Use prescription sleep medication medication know affect sleep contraindicate use hypnotic , unwilling unable discontinue study ; Known allergy eszopiclone ; Shift worker ; Pregnant , breastfeed plan pregnancy next 6 month ; Previous cognitive behavioral therapy insomnia current psychotherapy ; Prior MBSR class regularly practice mindfulness meditation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>mindfulness</keyword>
	<keyword>meditation</keyword>
	<keyword>MBSR</keyword>
	<keyword>mindfulness meditation</keyword>
	<keyword>sleep</keyword>
	<keyword>insomnia</keyword>
	<keyword>chronic insomnia</keyword>
	<keyword>primary insomnia</keyword>
	<keyword>Minnesota</keyword>
</DOC>